Summary & Overview
CPT 80061: Lipid Panel Laboratory Test
CPT code 80061 is a widely utilized laboratory billing code for the lipid panel, a critical test in the assessment and management of cardiovascular health. The lipid panel measures key blood lipids, including cholesterol and triglycerides, providing essential information for diagnosing and monitoring conditions such as hyperlipidemia and related disorders. This code is frequently billed in office settings and is a cornerstone of preventive care protocols across the United States.
Major national payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. The publication offers insights into payer coverage policies, common billing practices, and relevant clinical contexts for CPT 80061. Readers will find information on associated modifiers, provider taxonomies, and ICD-10 diagnoses that support medical necessity for lipid panel testing. Additionally, the report highlights related CPT codes that are often billed in conjunction with 80061, providing a comprehensive overview of laboratory testing for lipid disorders.
This summary equips healthcare professionals, billing specialists, and policy analysts with up-to-date benchmarks and policy considerations for the lipid panel, ensuring clarity on payer requirements and clinical indications. The content is structured to support informed decision-making in laboratory billing and compliance.
CPT Code Overview
CPT 80061 represents a lipid panel, a laboratory test used to measure cholesterol and triglyceride levels in the blood. This panel is essential for assessing cardiovascular risk and monitoring lipid disorders. The service type is laboratory, and the typical site of service is an office setting (Place of Service 11). Lipid panels are commonly ordered by healthcare providers to evaluate patients for hyperlipidemia and related conditions, supporting preventive care and ongoing management of heart health.
Clinical & Coding Specifications
Clinical Context
A patient presents to a primary care office for a routine check-up or follow-up visit. The provider orders a lipid panel (80061) to assess the patient's cholesterol and triglyceride levels. This test is commonly performed for patients with known or suspected hyperlipidemia, cardiovascular risk factors, or as part of preventive screening for lipoid disorders. The specimen is collected in the office (Place of Service 11) and may be processed onsite or sent to a reference laboratory. Results inform diagnosis, management, and monitoring of lipid-related conditions.
Coding Specifications
-
Modifiers:
- Modifier
90: Reference (Outside) Laboratory. Used when the laboratory test is performed by an outside laboratory rather than the provider's own facility. - Modifier
91: Repeat Clinical Diagnostic Laboratory Test. Used when the same laboratory test is repeated on the same patient on the same day to obtain additional information.
- Modifier
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
291U00000X | Clinical Medical Laboratory |
207Q00000X | Family Medicine Physician |
207R00000X | Internal Medicine Physician |
These taxonomies represent the clinical laboratory performing the test and the physicians who commonly order lipid panels.
Related Diagnoses
-
E78.5: Hyperlipidemia, unspecified- Used when the patient has elevated lipid levels without further specification; commonly prompts ordering a lipid panel.
-
E78.0: Pure hypercholesterolemia- Indicates elevated cholesterol; lipid panel helps quantify and monitor cholesterol levels.
-
E78.1: Pure hyperglyceridemia- Indicates elevated triglycerides; lipid panel measures triglyceride concentration.
-
E78.2: Mixed hyperlipidemia- Used when both cholesterol and triglycerides are elevated; lipid panel provides necessary data for diagnosis and management.
-
Z13.220: Encounter for screening for lipoid disorders- Used for preventive screening; lipid panel is the primary test for detecting lipoid disorders in asymptomatic patients.
Related CPT Codes
-
83718: Lipoprotein, direct measurement, HDL cholesterol- Measures HDL cholesterol directly; often performed as part of or in addition to a lipid panel.
-
84478: Triglycerides- Measures triglyceride levels; included in the lipid panel or ordered separately if needed.
-
80053: Comprehensive metabolic panel- Assesses a broader range of metabolic parameters; may be ordered alongside a lipid panel for comprehensive evaluation.
-
83036: Hemoglobin A1c- Used to assess glycemic control; commonly ordered with lipid panels in patients with diabetes or metabolic syndrome.
These codes are frequently used together in clinical workflows for cardiovascular risk assessment, diabetes management, and preventive care.
National Reimbursement Benchmarks
Nationally, the mean rate for CPT code 80061 among commercial payers (BUCA) is $14.57, which is higher than the UnitedHealth Group mean rate of $11.48 and the Blue Cross Blue Shield mean rate of $12.71. Cigna has the highest mean rate at $18.54, while Aetna is also above the BUCA average at $16.94.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. UnitedHealth Group shows the tightest range at $6.50, while Cigna has the widest spread at $13.00. Blue Cross Blue Shield and BUCA have moderate dispersion, with ranges of $6.90 and $7.17, respectively. Aetna's range is $9.00, indicating a broader spread than most but less than Cigna.
The table and chart below present the full breakdown of national benchmarks for CPT code 80061 by payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.